Loading...
XSHE
300206
Market cap1.04bUSD
Jul 10, Last price  
12.04CNY
1D
-0.99%
1Q
-18.37%
Jan 2017
26.74%
IPO
95.38%
Name

Edan Instruments Inc

Chart & Performance

D1W1MN
XSHE:300206 chart
P/E
22.83
P/S
3.49
EPS
0.53
Div Yield, %
1.70%
Shrs. gr., 5y
Rev. gr., 5y
4.08%
Revenues
2.00b
+8.97%
175,857,052228,922,673320,608,955375,294,090382,458,305454,607,048522,775,626550,136,390698,007,759843,277,974992,719,6251,136,243,0202,318,604,2311,636,411,0421,742,412,2981,742,412,2971,937,988,9171,834,376,5911,998,852,476
Net income
306m
+88.54%
28,398,06245,906,52466,015,91059,185,78555,195,70434,702,86513,432,779103,209,22826,352,75543,766,98592,654,984131,850,513653,153,459231,436,444232,942,289232,942,292221,301,113162,109,424305,637,857
CFO
353m
-4.98%
34,902,28147,878,61165,511,59544,101,25980,780,88330,125,8037,986,94928,451,8300113,960,81582,336,899115,288,444689,500,602237,283,290335,157,849153,961,216371,360,642352,882,179
Dividend
May 27, 20250.207 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Edan Instruments, Inc. is a global provider specializing in the development, manufacturing, and worldwide distribution of a comprehensive range of medical equipment. Their diagnostic electrocardiograph (ECG) portfolio covers a variety of solutions, such as resting ECG, stress testing, Holter monitoring, wireless options, and dedicated ECG workstations. For patient monitoring, Edan offers systems addressing vital signs, transport, central monitoring, and various levels of care—from high acuity to acute and sub-acute settings—along with telemetry and pulse oximetry devices. In the field of obstetrics and gynecology, their offerings include fetal and maternal monitoring systems, fetal telemetry, ultrasonic Doppler devices, and video colposcopes. The company's ultrasound imaging systems encompass both color Doppler and black-and-white digital units. Additionally, Edan provides in-vitro diagnostics (IVD) like hematology analyzers, and a suite of point-of-care testing (POCT) systems, including analyzers for blood gas and chemistry, magnetic immunoassay, and colloidal gold-labeled immunoassay. They also cater to the veterinary market with specialized ultrasound, ECG, ABG, and monitoring products. Edan Instruments, Inc. maintains its headquarters in Shenzhen, People's Republic of China.
IPO date
Apr 21, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT